Back to results
US 10,132,806 B2Granted
Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
AssigneeAugurex Life Sciences Corp.
InventorAnthony Marotta
Life of this patent
Estimating the term…
Abstract
The present invention provides citrullinated 14-3-3η peptides and antibodies thereto and methods of using same to evaluate arthritic conditions such as rheumatoid arthritis.
Claims6
A method for diagnosing Rheumatoid Arthritis in a subject comprising:
- i) obtaining a biological sample from a subject suspected of having or at risk for developing Rheumatoid Arthritis,
- ii) contacting said biological sample from the subject with at least one citrullinated 14-3-3 eta protein or fragment thereof comprising at least one citrullinated 14-3-3 eta epitope under a condition suitable for the formation of at least one immune complex between the citrullinated 14-3-3 eta protein or fragment thereof and autoantibodies specific for said citrullinated 14-3-3 eta epitope that may be present in the biological sample, wherein said citrullinated 14-3-3 eta epitope comprises a citrulline residue at a position selected from the group consisting of position 4, position 12, position 19, position 42, position 61, position 86 and position 227 of SEQ ID NO:
- 5;
- and
- iii) detecting the presence of immune complexes between the citrullinated 14-3-3 eta protein or fragment thereof and autoantibodies that specifically bind the citrullinated 14-3-3 eta epitope of the citrullinated 14-3-3 eta protein or fragment thereof, wherein said presence of said immune complexes is indicative of Rheumatoid Arthritis in said subject.
2 more elements
Dependencies are inferred from the claim text.